Multiple sclerosis, relapsing-remitting Trials in Portland, United States
Conditions / Multiple sclerosis, relapsing-remitting / Portland, United States
Multiple sclerosis, relapsing-remitting has been the subject of sustained clinical investigation across multiple research sites.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02315872 | ACTH for Fatigue in Multiple Sclerosis Patients | COMPLETED | PHASE3 |
| NCT01116427 | A Cooperative Clinical Study of Abatacept in Multiple Sclerosis | COMPLETED | PHASE2 |
| NCT02637856 | A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) | COMPLETED | PHASE3 |
| NCT00027300 | Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT00306592 | Natalizumab Re-Initiation of Dosing | COMPLETED | PHASE3 |
| NCT00595920 | Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis | TERMINATED | PHASE2 |
| NCT03500328 | Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial | ACTIVE_NOT_RECRUITING | NA |
| NCT03689972 | A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration | COMPLETED | PHASE3 |
| NCT00030966 | Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT06408259 | Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis | RECRUITING | — |